Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.
Abstract
no Abstract
Author
Abhishek, Abhishek
Boyton, Rosemary J
Peckham, Nicholas
McKnight, Áine
Coates, Laura C
Bluett, James
Barber, Vicki
Cureton, Lucy
Francis, Anne
Appelbe, Duncan
Eldridge, Lucy
Julier, Patrick
Valdes, Ana M
Brooks, Tim
Rombach, Ines
Altmann, Daniel M
Nguyen-Van-Tam, Jonathan S
Williams, Hywel C
Cook, Jonathan A
Boyton, Rosemary J
Peckham, Nicholas
McKnight, Áine
Coates, Laura C
Bluett, James
Barber, Vicki
Cureton, Lucy
Francis, Anne
Appelbe, Duncan
Eldridge, Lucy
Julier, Patrick
Valdes, Ana M
Brooks, Tim
Rombach, Ines
Altmann, Daniel M
Nguyen-Van-Tam, Jonathan S
Williams, Hywel C
Cook, Jonathan A
Citations
Altmetric:
Date
2022-06-27
Type
Article
Subject
Collections
Citation
Abhishek A, Boyton RJ, Peckham N, McKnight Á, Coates LC, Bluett J, et al
Journal / Source Title
The Lancet Respiratory Medicine
DOI
10.1016/S2213-2600(22)00186-2
PMID
35772416
Publisher
Elsevier
Publisher’s URL
Doi:10.1016/S2214-2600(22)00186-2